{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:38:42Z","timestamp":1782448722983,"version":"3.54.5"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.hrthm.2021.11.028","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T02:15:40Z","timestamp":1637892940000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["An overview of heart rhythm disorders and management in myotonic dystrophy type 1"],"prefix":"10.1016","volume":"19","author":[{"given":"Thomas D.","family":"Gossios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Providencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Creta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver R.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis R.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Wahbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Savvatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2021.11.028_bib1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00415-017-8483-2","article-title":"The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research","volume":"264","author":"Wood","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ejhg.2012.108","article-title":"Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2","volume":"20","author":"Kamsteeg","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hrthm.2021.11.028_bib3","first-page":"154","article-title":"Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies","volume":"32","author":"Meola","year":"2013","journal-title":"Acta Myol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tcm.2019.06.001","article-title":"Cardiovascular manifestations of myotonic dystrophy","volume":"30","author":"Wahbi","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2021.11.028_bib5","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1212\/WNL.52.8.1658","article-title":"A 10-year study of mortality in a cohort of patients with myotonic dystrophy","volume":"52","author":"Mathieu","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2021.11.028_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.24766","article-title":"Relative risks for comorbidities associated with myotonic dystrophy: a population-based analysis","volume":"52","author":"Johnson","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hrthm.2021.11.028_bib7","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/eurheartj\/ehu157","article-title":"Cardiac involvement in myotonic dystrophy: a nationwide cohort study","volume":"35","author":"Lund","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2021.11.028_bib8","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1212\/WNL.0000000000006948","article-title":"A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management","volume":"92","author":"Lagrue","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2021.11.028_bib9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ahj.2010.07.032","article-title":"Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1","volume":"160","author":"Bhakta","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2021.11.028_bib10","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1128\/MCB.23.16.5489-5501.2003","article-title":"Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization","volume":"23","author":"Wansink","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib11","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1021\/bi992142f","article-title":"Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition","volume":"39","author":"Bush","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.hrthm.2021.11.028_bib12","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1074\/jbc.M412845200","article-title":"Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum","volume":"280","author":"Kaliman","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2021.11.028_bib13","doi-asserted-by":"crossref","first-page":"40296","DOI":"10.1074\/jbc.M111.241455","article-title":"Myotonic dystrophy protein kinase is critical for nuclear envelope integrity","volume":"286","author":"Harmon","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2021.11.028_bib14","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.3233\/JND-150088","article-title":"Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism","volume":"2","author":"Meola","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2021.11.028_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nmd.2014.11.018","article-title":"Abnormal sodium current properties contribute to cardiac electrical and contractile dysfunction in a mouse model of myotonic dystrophy type 1","volume":"25","author":"Algalarrondo","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hrthm.2021.11.028_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.acvd.2013.08.003","article-title":"Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1","volume":"106","author":"Wahbi","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2021.11.028_bib17","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1038\/ncomms11067","article-title":"Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy","volume":"7","author":"Freyermuth","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2021.11.028_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010393","article-title":"CRISPR-mediated expression of the fetal Scn5a isoform in adult mice causes conduction defects and arrhythmias","volume":"7","author":"Pang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2021.11.028_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0735-1097(88)91547-1","article-title":"Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases","volume":"11","author":"Nguyen","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.hrthm.2016.12.004","article-title":"Late gadolinium enhancement in Brugada syndrome: a marker for subtle underlying cardiomyopathy?","volume":"14","author":"Bastiaenen","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.11.028_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.eurheartj.a061011","article-title":"Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging","volume":"16","author":"De Ambroggi","year":"1995","journal-title":"Eur Heart J Jul"},{"key":"10.1016\/j.hrthm.2021.11.028_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.hrthm.2012.06.032","article-title":"Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging","volume":"9","author":"Turkbey","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.11.028_bib23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.0b013e3181dc1a3a","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"74","author":"Logigian","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2021.11.028_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.1992.tb05103.x","article-title":"Treatment of myotonia with antiarrhythmic drugs","volume":"86","author":"Kwiecinski","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.hrthm.2021.11.028_bib25","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.hrthm.2014.07.011","article-title":"Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: myotonic dystrophy as a part of the Brugada syndrome","volume":"11","author":"Maury","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.11.028_bib26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1540-8167.2002.00444.x","article-title":"Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length","volume":"13","author":"Groh","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1540-8159.2010.02905.x","article-title":"Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy","volume":"34","author":"Nazarian","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3233\/JND-140025","article-title":"DM1 patients with small CTG expansions are also at risk of severe conduction abnormalities","volume":"2","author":"Denicourt","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2021.11.028_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/heart.86.4.411","article-title":"Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?","volume":"86","author":"Clarke","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2021.11.028_bib30","article-title":"Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-Heart Registry","volume":"10","author":"Chong-Nguyen","year":"2017","journal-title":"Circ Cardiovasc Genet Jun"},{"key":"10.1016\/j.hrthm.2021.11.028_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00415-018-8773-3","article-title":"A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre","volume":"265","author":"Bucci","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2010.10.132","article-title":"Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system","volume":"156","author":"Magri","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/hrt.6.1.41","article-title":"The heart in myotonia atrophica","volume":"6","author":"Evans","year":"1944","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2021.11.028_bib34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0002-9149(84)80147-2","article-title":"Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients","volume":"54","author":"Perloff","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib35","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/01.CIR.60.6.1360","article-title":"The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies","volume":"60","author":"Prystowsky","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.11.028_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000174865","article-title":"The natural course of cardiac conduction disturbances in myotonic dystrophy","volume":"79","author":"Fragola","year":"1991","journal-title":"Cardiology"},{"key":"10.1016\/j.hrthm.2021.11.028_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2169\/internalmedicine1962.30.360","article-title":"Follow-up clinical electrophysiological studies in a patient with myotonic dystrophy","volume":"30","author":"Hiromasa","year":"1991","journal-title":"Jpn J Med"},{"key":"10.1016\/j.hrthm.2021.11.028_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/europace\/euq423","article-title":"Long-term follow-up of patients with myotonic dystrophy: an electrocardiogram every year is not necessary","volume":"13","author":"Brembilla-Perrot","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2021.11.028_bib39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.CIR.99.8.1041","article-title":"Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy","volume":"99","author":"Lazarus","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.11.028_bib40","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0735-1097(02)02339-2","article-title":"Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study","volume":"40","author":"Lazarus","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib41","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2021.11.028_bib42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2010.02.029","article-title":"Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices","volume":"150","author":"Laurent","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib43","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.2012.346","article-title":"Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease","volume":"307","author":"Wahbi","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2021.11.028_bib44","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacep.2021.01.017","article-title":"A normal electrocardiogram does not exclude infra-hisian conduction disease in patients with myotonic dystrophy type 1","volume":"7","author":"Creta","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib45","article-title":"Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: prognostic value and heart rate variability evolution","volume":"24","author":"Gamet","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2014.03.088","article-title":"High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study","volume":"174","author":"Petri","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1542-474X.2003.08310.x","article-title":"Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1","volume":"8","author":"Hardin","year":"2003","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib48","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1161\/CIR.0000000000000526","article-title":"Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association","volume":"136","author":"Feingold","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.11.028_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2011.07.085","article-title":"Implantable loop recorders in myotonic dystrophy 1","volume":"152","author":"Stollberger","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1540-8167.2002.00072.x","article-title":"Use of an insertable loop recorder in a myotonic dystrophy patient","volume":"13","author":"Hadian","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/pace.12260","article-title":"Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy","volume":"37","author":"Brembilla-Perrot","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nmd.2016.01.005","article-title":"Atrial flutter in myotonic dystrophy type 1: patient characteristics and clinical outcome","volume":"26","author":"Wahbi","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hrthm.2021.11.028_bib53","first-page":"1241","article-title":"Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis","volume":"19","author":"Russo","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.hrthm.2021.11.028_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jce.12821","article-title":"The role of the atrial electromechanical delay in predicting atrial fibrillation in myotonic dystrophy type 1 patients","volume":"27","author":"Russo","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib55","doi-asserted-by":"crossref","first-page":"383852","DOI":"10.4061\/2010\/383852","article-title":"Myotonic dystrophy initially presenting as tachycardiomyopathy successful catheter ablation of atrial flutter","volume":"2010","author":"Asbach","year":"2010","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.hrthm.2021.11.028_bib56","first-page":"142","article-title":"Atrial fibrillation burden in myotonic dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up","volume":"32","author":"Russo","year":"2013","journal-title":"Acta Myol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib57","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nmd.2007.01.014","article-title":"Relationship between cardiac arrhythmias and sleep apnoea in permanently paced patients with type I myotonic dystrophy","volume":"17","author":"Lazarus","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hrthm.2021.11.028_bib58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0735-1097(85)80286-2","article-title":"Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features","volume":"6","author":"Grigg","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib59","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2021.11.028_bib60","first-page":"751","article-title":"Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1","volume":"38","author":"Wahbi","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2021.11.028_bib61","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2007.09.073","article-title":"Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact","volume":"51","author":"Daubert","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib62","first-page":"154","article-title":"Cardiac resynchronization improves heart failure in one patient with myotonic dystrophy type 1. A case report","volume":"31","author":"Russo","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib63","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1540-8159.2007.00782.x","article-title":"Cardiac resynchronization therapy in a case of myotonic dystrophy (Steinert's disease) and dilated cardiomyopathy","volume":"30","author":"Kilic","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12968-019-0535-6","article-title":"Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality","volume":"21","author":"Cardona","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hrthm.2021.11.028_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JND-190415","article-title":"The added value of cardiac magnetic resonance in muscular dystrophies","volume":"6","author":"Lamacie","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2021.11.028_bib66","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/heartjnl-2015-308517","article-title":"Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy","volume":"102","author":"Choudhary","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2021.11.028_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2017.10.020","article-title":"Cardiac involvement in myotonic dystrophy: the role of troponins and N-terminal pro B-type natriuretic peptide","volume":"267","author":"Valaperta","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hrthm.2021.11.028_bib68","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014006","article-title":"Clinical care recommendations for cardiologists treating adults with myotonic dystrophy","volume":"9","author":"McNally","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2021.11.028_bib69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/AC.66.2.2071264","article-title":"Ventricular tachycardia: first manifestation of myotonic dystrophy","volume":"66","author":"Cakmak","year":"2011","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.hrthm.2021.11.028_bib70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2169\/internalmedicine.39.39","article-title":"Successful catheter ablation against ventricular tachycardia associated with myotonic dystrophy","volume":"39","author":"Shiraishi","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.hrthm.2021.11.028_bib71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.recesp.2012.08.011","article-title":"Cardiac manifestations in myotonic dystrophy type 1 patients followed using a standard protocol in a specialized unit","volume":"66","author":"Facenda-Lorenzo","year":"2013","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.hrthm.2021.11.028_bib72","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.CIR.98.6.541","article-title":"Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation","volume":"98","author":"Merino","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.11.028_bib73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2169\/internalmedicine.44.129","article-title":"Re-entry circuit in ventricular tachycardia due to focal fatty-fibrosis in a patient with myotonic dystrophy","volume":"44","author":"Muraoka","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.hrthm.2021.11.028_bib74","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/europace\/eul016","article-title":"Recurrent fascicular ventricular tachycardia in myotonic dystrophy","volume":"8","author":"Nageh","year":"2006","journal-title":"Europace"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527121024188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527121024188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:56:26Z","timestamp":1761548186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527121024188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1547527121024188"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2021.11.028","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of heart rhythm disorders and management in myotonic dystrophy type 1","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2021.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}